SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amcis informs about non-applicability of large corporate entity

17 May 2021 Evaluate
Reference to the SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 to the Companies with regard to fund raising by issuance of debt securities by large entities, Dishman Carbogen Amcis has informed that the Company is not a Large Corporate as per the applicability criteria given under the said SEBI circular as on 31st March, 2021. It is pertaining to note that the Company has also submitted necessary disclosure on 20th April, 2021 at BSE Listing Centre under 'Annual Disclosure' confirming that the Company is not fall under the criteria of Large Corporate as per the said SEBI circular.

The above information is a part of company’s filings submitted to BSE.

Dishman Carbogen Amc Share Price

167.55 -1.05 (-0.62%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×